Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/HiB vaccine compared to separate comcomitant injections of DTPa-IPV/HiB and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule. - Avdicova,M.; Prikazsky,V.V.; Hudeckova,H. (Eur J Pediatr, 2002)